HGH Fragment 176-191 5mg Product Information
HGH Fragment 176-191 5 mg research-grade lyophilized peptide powder in a glass vial. HGH Fragment 176-191 (also known as AOD-9604) is a synthetic C-terminal fragment of human growth hormone studied in experimental models of lipolysis, adipocyte metabolism and growth hormone receptor–related signaling. Research Use Only: All products are intended exclusively for laboratory and scientific research. Not for human or veterinary use. Purity High-purity research grade Form Lyophilized peptide powder Content 5 mg HGH Fragment 176-191 per vial Packaging Glass vial with sterile closure Storage Store lyophilized at 2–8 °C (desiccated, protect from light) Molecular formula C78 H123 N23 O23 S2 Molecular weight ≈ 1815.1 g·mol⁻¹ Sequence Tyr-Leu-Arg-Asp-Asn-Lys-Phe-His-Gly-Ser-Arg-Pro-Gly-Lys-Lys CAS number 221231-10-3 In laboratory workflows, lyophilized research peptides are typically handled with suitable sterile diluents such as bacteriostatic water (BAC). For a compatible research-only solvent, see Bacteriostatic water – 10 ml . Research Overview HGH Fragment 176-191 (AOD-9604) corresponds to the C-terminal 16–amino-acid region of human growth hormone. In experimental models it is used to investigate GH-fragment signaling, lipolytic pathways in adipocytes and metabolic regulation, while avoiding direct activation of full-length GH receptor mitogenic pathways. All studies remain strictly within laboratory/experimental contexts without therapeutic claims. Primary Research Areas Lipolysis & adipocyte metabolism: Experimental models assessing hormone-sensitive lipase activation, fatty acid release and triglyceride turnover in adipose tissue. Growth hormone fragment signaling: In vitro work on downstream pathways modulated by the 176-191 fragment compared with full-length GH, including cAMP and MAPK-related cascades. Metabolic & energy-balance research: Laboratory studies exploring body-composition and energy-expenditure pathways in controlled animal and cell-based models.
